EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer
Clinical trial NCT03494322 · COMPLETED
Trial details
- NCT number
- NCT03494322
- Sponsor
- University College, London
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-20
- Primary completion
- 2021-09-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.